This inaugural conference will be held virtually in 2021 and then every two to three years in Japan. This collaboration between the JCA and AACR will bring together the greatest minds from the United States, Japan, and around the world to share the latest and most exciting developments in precision cancer medicine.

September 10-12, 2021 (US)
September 11-12, 2021 (Japan)
Virtual Meeting

Visit Conference Website

Cochairs and Keynote Speakers

Hiroyuki Mano, National Cancer Center, Tokyo, Japan (JCA)
Elaine R. Mardis, Nationwide Children’s Hospital, Columbus, Ohio (AACR)

AACR Committee

Lillian L. Siu, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada
Elizabeth M. Jaffee, Johns Hopkins University, Baltimore, Maryland
Jeffrey W. Tyner, OHSU Knight Cancer Institute, Portland, Oregon
Deborah Schrag, Dana-Farber Cancer Institute, Boston, Massachusetts

JCA Committee

Takayuki Yoshino, National Cancer Center Hospital East (NCCHE), Kashiwa, Japan
Hiroyoshi Nishikawa,  National Cancer Center, Tokyo, Japan
Junko Takita, Kyoto University, Kyoto, Japan
Ryohei Katayama, Japanese Foundation for Cancer Research, Tokyo, Japan
Patrick Tan, Duke-NUS Medical School, Singapore
Seishi Ogawa, Kyoto University Graduate School of Medicine, Kyoto, Japan

Program Topics

• Plenary: Liquid Biopsy
• Plenary: Immunooncology
• Hematology
• Pediatric Cancer
• Drug Resistance
• Germline Predisposition
• Novel Platforms for Precision Medicine
• Research Focused on Asian Cancers
• AI in Precision Medicine
• Real-World Evidence in Precision Medicine
• Somatic Mutations in Precancerous Tissue
• Cancer Model Systems

*Session recordings will be available for on-demand viewing by registrants until December 31.

#JCAaacrPM21